<p><strong>Helium prices have roughly doubled since the Iran conflict began in early 2026, with global supply from Qatar — responsible for approximately one-third of world production — severely disrupted. For laboratories running gas chromatography and other helium-dependent instruments, the financial and operational impact is impossible to ignore.</strong></p><h3><strong>Part 1: The Helium Price Crisis — What Happened and Why It Matters to Your Lab</strong></h3><h4><strong>A Perfect Storm in the Helium Market</strong></h4><p>Helium has never been a cheap commodity, but what laboratories are facing in 2026 represents a genuine inflection point. The combination of escalating Middle East conflict, Strait of Hormuz shipping disruptions, and structural supply constraints has created the most severe helium pricing environment in recent memory — one that shows no sign of rapid reversal.</p><p>To understand why laboratory budgets are under pressure, it helps to understand where helium actually comes from. Unlike most industrial gases, helium cannot be manufactured. It is a byproduct of radioactive decay deep within the Earth's crust, and it must be captured from <a target="_blank" rel="noopener noreferrer" href="https://businessanalytiq.com/procurementanalytics/index/helium-price-index/"><strong>natural gas deposits </strong></a>before it escapes into the atmosphere. The practical result is that the entire world's commercial helium supply flows from a small number of producing regions — most critically, the United States and Qatar.</p><h4><strong>Qatar: The World's Helium Chokepoint</strong></h4><p>Qatar is responsible for approximately <a target="_blank" rel="noopener noreferrer" href="https://www.expertmarketresearch.com/price-forecast/helium-price-trends"><strong>one-third of global helium production</strong></a>, channeled through QatarEnergy LNG's massive purification facility at Ras Laffan Industrial City, which draws from the North Field — the world's largest non-associated natural gas reservoir. When this facility operates normally, it is the single largest stabilizing force in the global helium market. When it is disrupted, the entire world feels it.</p><p>In early 2026, it stopped operating normally. Iranian missile strikes damaged key industrial infrastructure in Qatar, and the resulting disruption to Ras Laffan created an immediate supply shock. Compounding the damage, the Strait of Hormuz — the critical shipping corridor through which Qatari LNG and helium exports must pass — became subject to elevated war-risk premiums and logistical disruptions that pushed shipping costs sharply higher.</p><h4><strong>Beyond Price: The Supply Reliability Problem</strong></h4><p>For laboratory managers, the helium crisis is not merely a budget problem — it is an operational continuity problem. A laboratory that cannot obtain helium cannot run its gas chromatography (GC) instruments, cannot perform MRI maintenance or calibration, and cannot complete analytical work that clients and researchers depend upon.</p><p>Supply allocation tightening, spot market shortages, and delays at ports serving Middle Eastern shipping lanes have created a new reality: even laboratories with long-term supply contracts have experienced <a target="_blank" rel="noopener noreferrer" href="https://www.procurementresource.com/resource-center/helium-price-trends"><strong>delivery disruptions</strong></a>. The gas that was once ordered and reliably delivered within a predictable lead time now arrives subject to geopolitical delays entirely outside the laboratory's control.</p><p>This represents a fundamental shift in risk exposure for laboratory operations. Helium's value to a laboratory was always its combination of technical performance and reliable availability. The second pillar of that value proposition has been significantly eroded.</p><h4><strong>Who Is Most Affected in the Laboratory Setting?</strong></h4><p>While the helium price surge affects any organization that uses the gas, laboratories face a particularly acute version of the problem for several reasons:</p><ul><li><a target="_blank" rel="noopener noreferrer" href="https://gcms.labrulez.com/products?category=98&amp;manufacturerItems=540"><strong>GC carrier gas</strong></a><strong> consumption: </strong>Gas chromatography is one of the largest industrial uses of high-purity helium. Analytical laboratories running continuous GC workflows — environmental testing, pharmaceutical QC, food safety, petrochemical analysis — consume helium at a high, predictable rate. When the price of that gas doubles, it represents a direct and substantial increase in the variable cost of every single analytical run.</li><li><strong>No short-term substitution:</strong> Unlike some industrial uses where helium can be temporarily swapped for another gas, GC methods are validated for specific carrier gases. Switching requires revalidation — a time-consuming, resource-intensive process that cannot be completed in response to an acute supply disruption.</li><li><strong>Contractual and regulatory obligations: </strong>Laboratories operating under accreditation, client contracts, or regulatory frameworks face potential non-compliance consequences if supply disruptions prevent them from completing required analyses. The cost of a helium shortage extends far beyond the gas itself.</li></ul><h3><strong>Part 2: The Strategic Case for Switching to Hydrogen — and Installing a Generator</strong></h3><h4><strong>Hydrogen as a Carrier Gas: The Science Is Already Settled</strong></h4><p>The argument for<strong> </strong><a target="_blank" rel="noopener noreferrer" href="https://www.organomation.com/hydrogen-generators-for-chromatography"><strong>hydrogen as a GC carrier gas</strong></a><strong> </strong>is not new, and it is not driven solely by economics. For many applications, hydrogen is technically superior to helium. Its higher diffusivity in the column results in faster analyte movement, enabling shorter run times and higher throughput without loss of resolution. The van Deemter curve for hydrogen is flatter over a wider range of flow rates, giving analysts more operating flexibility.</p><p>The US EPA, the European pharmacopoeias, and numerous international standards bodies have long recognized hydrogen as an acceptable — and in some cases preferred — carrier gas for GC methods. Chromatography column and instrument manufacturers including Agilent, Shimadzu, PerkinElmer, and Thermo Fisher have published detailed application notes and validated methods for hydrogen carrier gas, often demonstrating equivalent or improved performance relative to helium.</p><p><strong>In short:</strong> <a target="_blank" rel="noopener noreferrer" href="https://www.organomation.com/transitioning-from-helium-to-hydrogen-what-you-need-to-know"><strong>switching from helium to hydrogen</strong></a><strong> </strong>for GC is not an experimental or unproven step. It is a well-established, widely validated practice that thousands of laboratories around the world have already completed. The <a target="_blank" rel="noopener noreferrer" href="https://www.cruxinvestor.com/posts/helium-prices-surge-400-to-record-highs-as-global-supply-shortage-persist-in-the-rise-of-ai"><strong>current pricing environment</strong></a><strong> </strong>simply makes the decision more urgent — and the financial case more compelling — than it has ever been before.</p><h4><strong>Why Cylinders Are Not the Answer</strong></h4><p>It might be tempting to view the hydrogen transition simply as swapping one gas cylinder supplier for another. This approach misunderstands both the nature of the problem and the opportunity. Hydrogen delivered in cylinders carries its own logistical challenges: cylinder handling and storage requirements, regular delivery schedules, the same kind of supply chain dependencies that have proven so costly with helium, and — critically — safety considerations around the storage of high-pressure hydrogen in laboratory spaces.</p><p>The correct solution, adopted by the most forward-thinking laboratory managers, is to install an on-site hydrogen generator. This single decision transforms the laboratory's gas supply from a variable, externally-dependent cost into a stable, internally-controlled utility — analogous to the difference between buying bottled water and installing a purified water system.</p><h4><strong>The Hydrogen Generator Advantage: Six Reasons to Make the Switch</strong></h4><h5><strong>1. Complete Supply Independence</strong></h5><p>A hydrogen generator produces gas on demand from deionized water using electrolysis. There is no supply chain to be disrupted by conflict in the Middle East. There is no shipping container to be delayed at a port. There is no cylinder to run out mid-run. The laboratory's hydrogen supply is as reliable as its electricity supply — and in most facilities, that is extremely reliable.</p><p>For laboratory managers who have spent the past year managing helium allocation anxiety, explaining supply disruptions to clients, and rescheduling analytical work around delivery delays, this represents a profound operational upgrade.</p><h5><strong>2. Long-Term Cost Predictability and Savings</strong></h5><p>Hydrogen generators produce gas at a cost primarily determined by electricity consumption. Electricity prices, while subject to some variation, are dramatically more stable than helium spot markets and are not subject to geopolitical disruptions of the kind that have driven helium prices to double in a matter of months.</p><p>The total cost of ownership analysis for hydrogen generation versus helium cylinder purchase — factoring in current helium pricing, cylinder rental fees, delivery charges, and handling costs — now firmly favors hydrogen generation for any laboratory running one or more GC instruments full-time. With helium prices having doubled since the onset of the Iran conflict, the payback period for a generator investment has shortened significantly.</p><h5><strong>3. Superior Gas Purity and Consistency</strong></h5><p><a target="_blank" rel="noopener noreferrer" href="https://gcms.labrulez.com/products?category=98&amp;manufacturerItems=540"><strong>Modern hydrogen generators </strong></a>produce gas at <strong>purities of 99.9999% or higher </strong>— exceeding the purity specifications required for the most demanding analytical GC applications. Critically, this purity is consistent from the first milliliter of gas produced to the last. There is no batch-to-batch variation, no risk of receiving a cylinder with a contamination issue, and no requirement to test incoming gas quality.</p><p>For laboratories operating under strict quality systems — ISO 17025, GMP, EPA method compliance — the shift to a generator can actually improve data quality and simplify the supplier qualification burden associated with managing a rotating roster of gas cylinder suppliers.</p><h5><strong>4. Improved Laboratory Safety Profile</strong></h5><p>Hydrogen requires appropriate safety management — adequate ventilation, hydrogen-compatible fittings, and basic leak detection protocols. These requirements are straightforward and well-understood, and are entirely manageable in a standard analytical laboratory environment. Modern hydrogen generators include integrated safety systems including automatic shutdown on leak detection, pressure limiting, and fail-safe electronics.</p><p>What is often overlooked is that a hydrogen generator improves overall laboratory safety relative to the cylinder-based alternative by eliminating the need to store and handle high-pressure compressed gas cylinders. The generator contains only a small volume of hydrogen at any given time — far less than a standard gas cylinder — and delivers it directly to the instrument through short, fixed lines.</p><h5><strong>5. Environmental and Sustainability Benefits</strong></h5><p>Helium extraction is an energy-intensive industrial process. The gas must be separated from natural gas streams, compressed, liquefied, and transported globally — often by sea freight from <a target="_blank" rel="noopener noreferrer" href="https://businessanalytiq.com/procurementanalytics/index/helium-price-index/"><strong>Qatar or the United States</strong></a>. Each step in that chain carries an environmental cost.</p><p>Hydrogen generation from water electrolysis has a fundamentally different environmental profile, particularly for laboratories that operate in facilities with access to renewable electricity. As laboratory sustainability programs become an increasing priority — driven by institutional ESG commitments, client expectations, and regulatory trends — the ability to point to an on-site, low-carbon gas supply is a meaningful differentiator.</p><h5><strong>6. Future-Proofing Against Ongoing Helium Market Instability</strong></h5><p>The current price spike is not an anomaly that will self-correct quickly. The structural conditions driving helium price increases — concentrated supply in geopolitically exposed regions, growing demand from semiconductor manufacturing and MRI imaging, the irreversibility of atmospheric helium loss once released — are not going away. New supply projects in South Africa, Canada, and elsewhere will add capacity over the medium term,but forecasters broadly expect helium pricing to remain elevated relative to historical norms.</p><p>A laboratory that installs a hydrogen generator today is not just solving the 2026 problem. It is making a strategic decision that positions the organization to be independent of whatever the next helium supply shock looks like.</p><p><strong>At a Glance: Helium Cylinder vs. On-Site Hydrogen Generation</strong></p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Organomation_The_Helium_Crisis_Is_Here_Why_Laboratories_Should_Switch_to_Hydrogen_Now_2_77969fd7aa.jpg" alt="Organomation: The Helium Crisis Is Here: Why Laboratories Should Switch to Hydrogen Now" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Organomation_The_Helium_Crisis_Is_Here_Why_Laboratories_Should_Switch_to_Hydrogen_Now_2_77969fd7aa.jpg 209w," sizes="100vw" width="1007" height="750"></p><h4><strong>How Organomation Supports Your Transition to Hydrogen</strong></h4><p>At Organomation, we have been supporting analytical laboratories with precision gas handling and concentration equipment for over six decades. We understand that the decision to transition carrier gases is not made lightly — it involves instrument requalification, method validation, staff training, and procurement changes that require planning and support.</p><p>Our team, in combination with <a target="_blank" rel="noopener noreferrer" href="https://claind.it/"><strong>Claind srl</strong></a>, can assist laboratories at every stage of the hydrogen transition: from initial feasibility assessment and instrument compatibility review, through gas flow optimization and generator sizing, to ongoing technical support after installation. We work with the leading hydrogen generator manufacturers and can help you specify the right system for your instrument fleet and throughput requirements.</p><p>The current helium pricing environment has created a narrow window in which laboratories that act decisively will establish a structural cost and reliability advantage over those that continue to absorb rising helium costs. We invite you to start that conversation with us today.</p><p>Contact the Organomation team to schedule a complimentary laboratory gas assessment and begin your transition to on-site hydrogen generation. Visit organomation.com or call us to speak with an applications specialist.</p><h4><strong>The Moment to Act Is Now</strong></h4><p>The helium crisis of 2026 is not a temporary inconvenience — it is a structural realignment of the global gas supply market, accelerated by a geopolitical conflict whose resolution timeline remains uncertain. Laboratories that approach this as a passing disruption to be absorbed through budget adjustments are likely to find themselves absorbing those costs indefinitely.</p><p>The case for switching to hydrogen carrier gas and installing an on-site hydrogen generator has never been more compelling. The technology is proven, the performance is validated, the safety is manageable, and the economics — already favorable before the current price surge — are now overwhelmingly advantageous.</p><p>The laboratories that will emerge from this crisis in the strongest position are those that use it as the catalyst to make a change they should have made years ago. The question is no longer whether to make the switch — it is how quickly you can do it.</p>

The Helium Crisis Is Here: Why Laboratories Should Switch to Hydrogen Now

<p><strong>A new study published in Nucleic Acids Research identifies short “start–stop” elements as highly effective regulators of protein synthesis in human cells. The study was co-led by Leoš Shivaya Valášek from IMIC CAS.</strong></p><section><div><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/MBU_Nenapadne_start_stop_brany_reguluji_tvorbu_bilkovin_v_bunce_2_4d91bb348d.jpg" alt="MBU: Unassuming Start–Stop “Gates” Regulate Protein Production in Cells" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_MBU_Nenapadne_start_stop_brany_reguluji_tvorbu_bilkovin_v_bunce_2_4d91bb348d.jpg 245w," sizes="100vw" width="720" height="390"></p><section><div><p>An international team of scientists has described a&nbsp;previously overlooked mechanism that regulates the levels of important proteins in human cells. A new study published in <strong>Nucleic Acids Research </strong>reveals that short regulatory “start–stop“ elements act as highly effective speed-limiting gates of protein synthesis. Compared with previously known regulatory sequences, these elements were found to suppress protein production even more efficiently. At the same time, they help maintain low but stable levels of important proteins in cells, even under stress conditions. The study brought together scientists from the <strong>United States, the Czech Republic, Canada, and Sweden</strong>. <strong>Leoš Shivaya Valášek</strong>, Head of the <strong>Laboratory of Regulation of Gene Expression </strong>at the <strong>Institute of Microbiology of the Czech Academy of Sciences (IMIC CAS)</strong> was a&nbsp;co-author and one of the corresponding authors of the study.</p></div></section><section><div><p>During protein production, ribosomes read and translate information encoded in messenger RNA (mRNA) into amino acids, which are then assembled into a&nbsp;new protein. The researchers focused on an unusual sequence in which a&nbsp;start signal is immediately followed by a&nbsp;stop signal. As a&nbsp;result, the ribosome receives instructions to begin and terminate translation almost simultaneously. Although such an arrangement may appear illogical, it proved to be an important regulatory tool.</p><p><strong>Start–stop motifs </strong>are found in more than <strong>1,400 human genes</strong> and are particularly common in genes that control cellular signaling pathways, the stress response, or the activity of transcription factors—that is, proteins that regulate the activity of other genes. These genes must be tightly controlled because even small changes in the amount of their protein products can have significant biological consequences.</p><h4><strong>Resilience Under Stress</strong></h4><p>The researchers tested the activity of this regulatory mechanism under stress conditions, including in the ATF4 gene, which plays a&nbsp;key role in the so-called integrated stress response. Cellular stress is typically associated with a&nbsp;global reduction in protein synthesis. The authors demonstrated that regulation mediated by start-stop elements is largely independent of the overall state of translation initiation and therefore remains effective even under cellular stress.</p><h4><strong>A Stronger Brake Than Known Regulatory Elements</strong></h4><p>The team compared start–stop sequences with similar regulatory regions known as uTranslons. Although both types of elements suppress protein synthesis, the start–stop sequences proved to be significantly more effective. Ribosomes remain associated with these motives for longer before proceeding to the main coding region of the gene.</p><p><i>“Start-stop sequences are specialized regulatory elements that ensure increased ribosome retention, thereby allowing for fine-tuning translation,” </i>says Leoš Valášek from IMIC CAS.</p><p>The study expands our understanding of how cells fine-tune protein synthesis and may ultimately contribute to research on &nbsp;certain cancer and neurodegenerative disorders, and other diseases linked to disrupted protein production.</p></div></section><blockquote><h4><strong>The original article</strong></h4><h4><a target="_blank" rel="noopener noreferrer" href="https://academic.oup.com/nar/article/54/13/gkag627/8725953?login=false"><strong>Elongationless start–stop elements are stress-resilient translation gates that are more repressive than uTranslons</strong></a></h4><p>Justin Rendleman, Solomon A Haizel, Shaohuan Wu, Laurelle Lee Young, Junjie Liu, Xinyi Ge, Huijing Zou, Mahabub Pasha Mohammad, Matthew Pressler, Shuvadeep Maity, Vladislava Hronová, Zhaofeng Gao, Anna Hermannová, Anna Smirnova, Amy Lei, Kristina Allgoewer, Daniel Sultanov, Will Edward Hinckley, Ziyue Cheng, Lauren Shelby, Tanubrata Dey, Krzysztof J Szkop, Ivan Topisirovic, Ola Larsson, Maria Hatzoglou, Leoš Shivaya Valášek, Christine Vogel</p><p><i><strong>Nucleic Acids Research</strong> </i>(2026), Volume 54, Issue 13&nbsp;</p><p><a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1093/nar/gkag627">https://doi.org/10.1093/nar/gkag627</a></p><h6>licenced under <a target="_blank" rel="noopener noreferrer" href="https://creativecommons.org/licenses/by/4.0/"><strong>CC-BY 4.0</strong></a></h6></blockquote><h4><strong>Abstract</strong></h4><p>Start–stop elements are translation regulatory elements in 5′ untranslated regions (UTR) of eukaryotic transcripts, consisting of a start codon immediately followed by a stop codon. In contrast to canonical upstream Translons (uTranslons), they exclude elongation which creates unique properties. We conducted a comprehensive, carefully controlled comparison of human start–stop elements and uTranslons both at a genome-wide level and with targeted reporter assays. We found that start–stops and uTranslons were similar with respect to their presence in the 5′ UTRs of hundreds of genes, in particular transcription factors and signaling molecules, the low transcript levels of the corresponding genes, short RNA half-lives, and the negative effect on downstream translation. However, start–stop containing genes were translationally even more repressed than genes with uTranslons. Analysing the start–stop architecture and diverse ribosome footprinting datasets, we found evidence for a start–stop-specific mechanism that involves repeat cycling between initiation, termination, ribosome splitting, and 60S rejoining—a process possibly modulated by ASCC3 and eIF1. This cycling explained increased ribosome retention at start–stops and was—in contrast to ribosome retention at uTranslons—independent of the global initiation state. Finally, we showed that the start–stop element in human <i>ATF4</i> augments the core regulatory model by controlling translation of the uTranslons.</p></div></section>

Unassuming Start–Stop “Gates” Regulate Protein Production in Cells

Why Biologics QC Is So Much Harder Than Small Molecule Pharma

Article

Product

Scientists

Interview

Science and research

The Czech Academy of Sciences (CAS) was established by Act No. 283/1992 Coll. as the Czech successor of the former Czechoslovak Academy of Sciences. It is set up as a complex of 54 public research institutions.

Czech Academy of Sciences

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Agilent Technologies

Technology Networks

Phenomenex

Thermo Fisher Scientific

SelectScience

SciY/Mestrelab Research

Waters Corporation

<p><strong>Renewable energy resources such as solar are promising complements to the combustion of fossil fuels. However, the intermittent and diurnal nature of sunlight necessitates economical and efficient energy storage technologies. A promising approach to both storing solar energy and generating combustible liquid fuels is driving the transformation of abundant energy-poor feedstocks (CO2, H2O) into energy-dense liquid fuels using energy from solar photons, known as “artificial photosynthesis.”&nbsp;</strong></p><p>One approach for artificial photosynthesis is to immobilize fuel-producing molecular catalysts onto light-absorbing semiconductor materials to create “hybrid photoelectrodes,” allowing for both the stability of heterogenous surfaces and the tunability of molecular catalysts. The Center for Hybrid Approaches in Solar Energy to Liquid Fuels (CHASE) is a multi-institutional energy innovation hub which aims to advance hybrid photoelectrodes for the light-driven generation of liquid fuels from CO2 and H2O. A variety of chemical techniques, including sonochemical hydrosilylation, π-π stacking, and electrochemical grafting, are utilized to anchor ruthenium and rhenium molecular CO2-reduction catalysts to a silicon surface.&nbsp;</p><p>To study the efficacy of these catalyst loading techniques, Inductively Coupled Plasma Mass Spectrometry (employing an Agilent 7850 ICP-MS) is leveraged to quantify catalyst surface coverage. Silicon samples are digested in an HNO3/HCl matrix to solubilize ruthenium and rhenium metal centers. As each anchored molecular catalyst contains one metal center, surface coverage estimates can be drawn by pairing ICP-MS data with the dimensions of the catalyst and the size of the silicon photoelectrode. From these data, key conclusions are drawn which correlate anchoring technique, reaction time, and silicon morphology to the loadings of these molecular catalysts. This information provides a guiding framework for next-generation designs of hybrid photoelectrodes.</p><blockquote><p><strong>Presenter:</strong> Jillian L. Dempsey (Director, Center for Hybrid Approaches in Solar Energy to Liquid Fuels (CHASE) and an Associate Editor for ACS Electrochemistry)</p><p>Jillian L. Dempsey is a professor at the University of North Carolina at Chapel Hill. She is currently the Director of the Center for Hybrid Approaches in Solar Energy to Liquid Fuels (CHASE) and an Associate Editor for ACS Electrochemistry.</p><p>Jillian received her S.B. from the Massachusetts Institute of Technology in 2005 where she worked in the laboratory of Prof. Daniel G. Nocera. As an NSF Graduate Research Fellow, she carried out research with Prof. Harry B. Gray and Dr. Jay R. Winkler at the California Institute of Technology, receiving her PhD in 2011. From 2011–2012 she was an NSF ACC Postdoctoral Fellow with Daniel R. Gamelin at the University of Washington.</p><p>In 2012, Jillian joined the faculty at the University of North Carolina at Chapel Hill. Her research group explores charge transfer processes associated with energy capture and conversion, including proton-coupled electron transfer reactions and electron transfer across interfaces. Her research bridges molecular and materials chemistry and relies heavily on methods of physical inorganic chemistry, including transient absorption spectroscopy and electrochemistry.</p><p>She has received numerous awards including the Harry B. Gray Award for Creative Work in Inorganic Chemistry by a Young Investigator (2019), the J. Carlyle Sitterson Award for Teaching First-Year Students (2017), a Sloan Research Fellowship (2016), a Packard Fellowship for Science and Engineering (2015), the Agnes Fay Morgan Research Award (2020), the University Award for Advancement of Women (2021), and the Brown Investigator Award (2026).</p></blockquote><blockquote><p><strong>Presenter: </strong>Rebecca E. Powers (Graduate Student, University of North Carolina at Chapel Hill)</p><p>Rebecca (Becca) E. Powers is a fourth-year graduate student at the University of North Carolina at Chapel Hill in Prof. Jillian L. Dempsey’s research group.</p><p>Becca graduated summa cum laude with a B.S. in Chemistry and B.S. in Physics from Creighton University in 2022. At Creighton University, she researched in the laboratories of Dr. Kayode Oshin and Dr. Janet Seger. While pursuing degrees in both chemistry and physics, Becca conducted research across both fields, including work on the Relativistic Heavy Ion Collider (RHIC) at Brookhaven National Laboratory. Becca was selected as both a Clare Boothe Luce fellow and a Goldwater Scholar during her undergraduate studies.</p><p>Becca joined Prof. Jillian Dempsey’s lab in 2022 and began researching as a part of the Center for Hybrid Approaches in Solar Energy to Liquid Fuels (CHASE). Her research explores the chemical and physical properties of semiconducting photoelectrodes for photon capture and solar fuel generation. Becca’s research utilizes a large range of techniques, including electrochemistry, inductively coupled plasma-mass spectroscopy (ICP-MS), X-ray photoelectron spectroscopy (XPS), and time-resolved infrared spectroscopy (TRIR). Becca’s outreach and research efforts have been recognized with a Prof. James Tamage Dobbins Award and UNC Chemistry Graduate Student Award for Research Excellence.</p></blockquote>

Agilent Technologies: ICP-MS for Hybrid Photoelectrode Characterization

ICP-MS for Hybrid Photoelectrode Characterization

Learn how the Agilent 7850 ICP-MS quantifies catalyst surface coverage on hybrid photoelectrodes to advance artificial photosynthesis and solar fuel research

Hybrid Photoelectrode Characterization via ICP-MS

<p><strong>Choosing the right internal standard is critical to achieving accurate, reliable ICP‑OES results—but knowing how and when to apply one isn’t always straightforward. In this webinar, we’ll review the fundamental principles of internal standardization in ICP‑OES and provide practical guidance on selecting the most appropriate internal standards for different elements, sample types, and analytical challenges. You’ll learn how internal standards help correct for signal drift, matrix effects, and sample introduction variability, as well as common pitfalls to avoid. Through real‑world examples, we’ll demonstrate how proper internal standard selection and implementation can improve data quality, confidence, and consistency across both routine and more challenging analyses.</strong></p><blockquote><p><strong>Presenter:</strong> Ana García González (Atomic Spectroscopy Application Scientist, Agilent Technologies)</p><p>Ana Garcia is the Atomic Spectroscopy Application Scientist at Agilent Technologies. Ana has a broad background in atomic spectroscopy technologies, including international experience developing and validating analytical spectroscopy methods for the geochemical industry. She has also published in the fields of molecular spectroscopy and chemometrics. Ana holds a MSc in plant Biotechnology at CINVESTAV, México, and a Bachelor of Science in Biotechnology Engineering.</p></blockquote>

Agilent Technologies: Learn to Select and Apply the Proper Internal Standard in ICP-OES

Learn to Select and Apply the Proper Internal Standard in ICP-OES

Learn how to select and apply internal standards in ICP-OES. Correct for matrix effects, signal drift, and sample introduction variability effectively

Selecting & Applying Internal Standards in ICP-OES

<p><strong>Laboratories are under growing pressure to handle increasing volumes of samples and data while operating under tighter regulatory inspection, all without compromising turnaround times or traceability. In this context, many organizations attempt to extend existing workflows and legacy tools, which can introduce inefficiencies, increase manual effort, and create compliance risks. At the same time, it is not always clear which digital solutions are best suited to address these challenges.</strong></p><p>This presentation illustrates how modern digital laboratory environments streamline routine activities by minimizing manual tasks and embedding compliance directly into everyday workflows. Drawing on a real-world use case, we show how automated capture of data from multiple sample measurements at the point of execution enables a continuous, sample-centric workflow.</p><p>By removing manual interventions and paper-based processes, laboratories can improve efficiency and visibility, support faster and more reliable decision-making while remaining responsive to evolving customer demands.</p><h4><strong>Learning Points</strong></h4><ul><li>The role of different systems (LIMS, SDMS, ELN) within the digital lab landscape and how they differ from each other's</li><li>How WebLab manages laboratory operations from a sample perspective, enabling you to track every sample, stage, and next action across workflows</li><li>How automated data capture from connected instruments helps reduce errors, lower contamination risks, and accelerate sample processing</li><li>You will see, through a real-life example, how integrated digital workflows improve data quality, accelerate reporting, and increase operational efficiency</li></ul><h4><strong>Who should attend</strong></h4><p>Professionals working in small to mid‑sized laboratories, including:</p><ul><li>Directors and Managers of Analytical, QC, or Contract Labs</li><li>Lab Operations and QA/QC Leaders</li><li>Digitalization and IT at organizations transitioning from paper, Excel, or legacy systems to LIMS</li></ul><blockquote><p><strong>Presenter:</strong> Peter Bellstedt, PhD (Director of Business Development and Product Manager at SciY)</p><p>Peter studied Biochemistry at the University of Jena before completing a PhD on the structural characterization of a DNA repair protein using solution and solid-state NMR. He was then appointed as the head of the NMR Spectroscopy Platform in Jena, Germany, where he pioneered the implementation of modern, highly efficient data-driven workflows. After five years, he moved to the University of Zurich, Switzerland, as a principal investigator, where his lab focused on structure-based drug discovery. This year, he brought his wealth of experience to the LOGS by SciY team, focusing on efficient workflow solutions for research labs and facilities on a global scale.</p></blockquote>

SciY: From Legacy Workflows to Paperless Labs: Track Every Sample, Process, and Decision

From Legacy Workflows to Paperless Labs: Track Every Sample, Process, and Decision

Transition from paper to a paperless lab. Discover how WebLab, LIMS, and automated data capture streamline sample tracking and boost compliance

Paperless Labs & Sample Tracking: Digital LIMS Workflows

<h4><strong>How about a 30 minute coffee break along with a bite of Empower?</strong></h4><h5><strong>Here you go!</strong></h5><p><strong>Faster Root Cause Analysis with Next-Generation LC and Empower™ Software</strong></p><p>Discover how next-generation LC systems connected to Empower software automatically capture critical system and method data, enabling faster troubleshooting and root cause analysis. Learn how to quickly identify the causes of peak tailing, reduced resolution, lower sensitivity, and other routine deviations while improving laboratory efficiency and confidence in your results.</p><h5><strong>Key takeaways:</strong></h5><ul><li>Automated data capture with connected LC systems and Empower</li><li>Faster identification of chromatographic issues</li><li>Improved troubleshooting efficiency and reduced downtime</li><li>Enhanced data integrity and compliance support</li></ul><p><strong>Prepare a coffee and attend!</strong></p><blockquote><p><strong>Speaker:</strong> Ralf Schröder (Informatics Market Development Manager)</p><p><strong>Speaker:</strong> Andrea Gheduzzi (Principal LC Market Development Manager)</p></blockquote>

Informatics series #34 Ready for Self-Documenting Chromatography?

Discover self-documenting LC with Waters Empower. Learn how connected LC systems automate root cause analysis and reduce troubleshooting downtime

Informatics series #34 Self-Documenting LC & Empower

<div><p><strong>Rapid microbial analysis is essential for maintaining product quality, ensuring safety, and supporting efficient laboratory workflows, yet selecting the most appropriate analytical approach can be challenging.</strong></p><p>This educational webinar explores three complementary methods—matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for microbial identification, Fourier transform infrared (FTIR) spectroscopy for microbial strain typing, and automated DNA/RNA electrophoresis for genetic analysis.</p><p>Through practical examples and application-focused discussion, attendees will gain a clearer understanding of each technique's strengths, limitations, and ideal use cases, helping them make more informed decisions when designing or optimizing microbial testing workflows.</p><p><strong>Attend this webinar to:</strong></p><ul><li>Understand how MALDI-TOF MS, FTIR, and automated DNA/RNA electrophoresis address different microbial analysis challenges</li><li>Learn how these three methods can support faster and more efficient microbial testing workflows</li><li>Evaluate which analytical approach is best suited to specific microbial testing applications and laboratory objectives</li><li>Apply practical considerations when implementing microbial identification, bacterial classification, or genetic analysis techniques in routine testing</li></ul><blockquote><p><strong>Presenter:</strong> Kaoru Nakagawa (Assistant Manager, Application Specialist (MALDI), Shimadzu Corporation)</p><p>Kaoru Nakagawa joined Shimadzu Corporation in 2008. She began her career at the Koichi Tanaka Mass Spectrometry Research Laboratory, where she developed highly sensitive glycan analysis methods using MALDI-MS with liquid-matrix-based on-plate labeling. Kaoru later moved to a customer-facing role, supporting applications such as, MALDI-MS imaging technologies, including on-tissue chemical derivatization. Today, her work focuses on developing rapid, practical methods for microbial identification using MALDI. Guided by Shimadzu’s corporate philosophy, “Contributing to society through science and technology,” she is dedicated to advancing mass spectrometry technologies that help address real-world scientific challenges.</p></blockquote><blockquote><p><strong>Presenter: </strong>Nozomi Maeshima (Assistant Manager, Application Specialist (Life Science), Shimadzu Corporation)</p><p>Nozomi Maeshima is an applications scientist at Shimadzu, where she has been involved in LC-MS application development in the life sciences field and in genetic analysis applications. She also leads promotional and marketing activities and supports customer inquiries. During university, she studied chemical biology and investigated the mechanisms of enzymes involved in biosynthetic processes. Nozomi brings a combination of research experience and applications expertise to help laboratories identify practical solutions for their analytical needs.</p></blockquote><blockquote><p><strong>Presenter:</strong> Xu Yan ( Assistant Manager, Application Specialist (FTIR), Shimadzu Corporation)</p><p>Xu Yan is an application chemist at Shimadzu Corporation with five years of experience developing FTIR applications for microbiology, environmental analysis, and GX-related fields. His work focuses on advancing practical FTIR applications and has gained extensive experience in method development and real-world implementation. In this session, Xu will present insights into the use of FTIR for microbiological analysis, including strain typing and related applications.</p></blockquote></div>

Technology Networks: Modern Methods for Faster Microbial Analysis

Modern Methods for Faster Microbial Analysis

Explore modern microbial analysis methods. Learn how MALDI-TOF MS, FTIR, and automated electrophoresis streamline identification, strain typing, and genetics

Modern Microbial Analysis: MALDI-TOF, FTIR & Electrophoresis

<p><strong>Wastewater surveillance has become an increasingly valuable approach for monitoring antimicrobial resistance (AMR) within a One Health framework. &nbsp;However, comprehensive characterization of antimicrobial resistance genes (ARGs) in complex environmental samples remains challenging using conventional methodologies alone.</strong></p><p>Join Helena Torrell, PhD, and Douglas Hurd, PhD, for a webinar discussing the challenges of antimicrobial resistance (AMR) surveillance in complex environmental samples and the growing need for sensitive, targeted genomic approaches. &nbsp;Douglas will provide an overview of Agilent’s SureSelect target enrichment technology prior to Next Generation Sequencing and its role in enhancing the detection of low-abundance gene sequences, before introducing guest speaker Helena Torrell, PhD. Helena will share her team’s innovative application of targeted hybridization capture for wastewater-based AMR surveillance.</p><p>This presentation will introduce a targeted hybridization capture strategy we developed to enhance the detection and characterization of known ARGs in environmental samples. &nbsp;Using hospital wastewater as a case study, the presentation will discuss the outstanding performance of our targeted enrichment approach for AMR surveillance, demonstrating its potential advantages and comparing its performance with untargeted shotgun metagenomic sequencing. The session will also address the opportunities and current limitations of targeted capture technologies for environmental resistome monitoring and their potential role in future surveillance programs.</p><h4><strong>Learning Objectives:</strong></h4><ol style="list-style-type:decimal;"><li>Learn how targeted capture improves ARG detection and environmental samples.</li><li>Compare targeted enrichment with shotgun metagenomic sequencing for AMR surveillance.</li><li>Explore the benefits and limitations of targeted capture for resistome monitoring</li></ol><blockquote><p><strong>Presenter:</strong> &nbsp;Helena Torrell Galceran, PhD ( Head of the Genomics Platform, Omic Sciences Unit, Eurecat Technology Center, Barcelona, Spain)</p><p>Helena Torrell, PhD in Biomedicine, is the Head of the Genomics Platform within the Omic Sciences Unit at Eurecat Technology Center (Barcelona, Spain). &nbsp;She specializes in microbial genomics, metagenomics, and next-generation sequencing technologies, with a particular focus on developing genomic tools for infectious disease research, antimicrobial resistance surveillance, and environmental monitoring. &nbsp;She leads the implementation of advanced sequencing technologies and supports multidisciplinary research projects aimed at translating genomic into practical applications for public health, clinical research, and the One Health framework.&nbsp;</p></blockquote><blockquote><p><strong>Presenter: &nbsp;</strong>Douglas Hurd, PhD (Field Application Scientist, Agilent)</p><p>Dr. Douglas Hurd has worked in Customer support and R&amp;D roles for many years within the Biotechnology industry. &nbsp;He currently supports Agilent’s genomics instrumentation and reagents, as well as the Automated electrophoresis instruments such as the TapeStation, Fragment Analyzer, and ProteoAnalyzer.</p></blockquote>

Agilent: Targeted Hybridization Capture for Antimicrobial Resistance Surveillance in Complex Environmental Samples

Targeted Hybridization Capture for Antimicrobial Resistance Surveillance in Complex Environmental Samples

Learn how Agilent SureSelect targeted hybridization capture enhances AMR surveillance and low-abundance ARG detection in complex wastewater samples

Targeted Capture for AMR Surveillance in Wastewater

<p><strong>This webinar provides a foundational overview of LC method optimization. The session will focus on parameters that are significant for method optimization, including column dimensions, sample loading, particle morphologies, silica specifications, and stationary phase selectivities. Attendees will gain insight into how to use method development tools for scalability, throughput, and reproducibility for their LC methods.</strong></p><h4><strong>Key Learning Points</strong></h4><ul><li>Understand your column, from hardware design through stationary phase.</li><li>Learn how to choose the right particle morphology to match your analytical objectives.</li><li>Master sample load scaling for consistent, reliable results.</li><li>Apply LC method scaling parameters to maximize throughput while maintaining reproducibility.</li></ul><h4><strong>Who Should Attend</strong></h4><ul><li>Any scientists and professionals working with liquid chromatography who want to learn about LC method optimisation during scaling for high throughput and preparative applications.</li></ul><h4><strong>One webinar, two viewing options</strong></h4><p>We know you're busy, select a viewing session that works best for you.</p><h5><strong>Viewing Options</strong></h5><p><strong>Session 1: Tuesday, September 1, 2026</strong></p><ul><li>Los Angeles: 10:00 AM PT&nbsp;</li><li>New York: 1:00 PM EST</li><li>Mexico City: 12:00 PM CDT</li></ul><p><strong>Session 2:Wednesday, September 2, 2026</strong></p><ul><li>London: 9:00 AM BST&nbsp;</li><li>Berlin: 10:00 AM CEST&nbsp;</li><li>Mumbai: 1:30 PM IST</li></ul><blockquote><p><strong>Speaker:</strong> Namrata Saxena (Technical Manager, Phenomenex)</p><p>&nbsp;Namrata Saxena is the Technical Manager for the Asia-Pacific region at Phenomenex and is part of the global technical team, she provides expert support for a wide range of chromatographic challenges particularly in the characterization of biotherapeutics and emerging cell and gene therapy modalities. Her role includes delivering technical training, hosting seminars and webinars, and contributing to scientific content development. Prior to joining Phenomenex, Namrata worked as a Product Specialist at Bischoff Chromatography GmbH in Germany where she gained extensive experience in stationary phase chemistry, column manufacturing and method development domains.&nbsp;</p></blockquote>

Phenomenex: Addressing LC Method Optimization - Scaling For Efficiency, Throughput And Reproducibility

Addressing LC Method Optimization - Scaling For Efficiency, Throughput And Reproducibility

Optimize and scale LC methods with confidence. Learn how column dimensions, particle morphology, and sample load impact throughput and reproducibility

LC Method Optimization: Scaling for High-Throughput Labs

<div><div container-id="cq-colctrl-lt0" comp-id="A1"><div><p><strong>Top-down mass spectrometry enables a proteoform-first approach by keeping the protein molecule intact, combining intact mass information with intact-ion fragmentation to support confident characterization of sequences, modifications, variants, and proteoforms. In this webinar, you will see how Thermo Scientific Proteoform Studio brings acquisition, analysis, visualization, and reporting together in a streamlined workflow for intact mass and top-down applications.</strong></p><h5><strong>By attending this webinar, you will learn how to:</strong></h5><ul><li><strong>Understand how top-down MS supports proteoform-first characterization:</strong> See how intact mass and intact-ion fragmentation can be used to characterize proteoforms, modifications, variants, and sequence coverage.</li><li><strong>See how Proteoform Studio simplifies acquisition, analysis, and reporting: </strong>Learn how integrated instrument control, interactive deconvolution, targeted top-down method creation, database management, result review, and automated reports can reduce workflow complexity.</li><li><strong>Learn how Direct Mass Technology™ and automated workflows can improve data quality and productivity: </strong>Explore how Direct Mass Technology™, automated charge assignment, data aggregation, and proteoform tracks can help improve sequence coverage, simplify comparison, and support deeper characterization.</li></ul><h5><strong>Topics covered:</strong></h5><ul><li>Why top-down mass spectrometry matters</li><li>Proteoform Studio for intact protein characterization</li><li>Interactive deconvolution and walk-up analysis</li><li>Mixed and sliding-window deconvolution</li><li>Targeted top-down method creation</li><li>Direct Mass Technology™ workflows</li><li>Proteoform tracks and data aggregation</li><li>Automated reporting</li></ul><p>You will leave with a practical understanding of how Proteoform Studio can help streamline intact mass and top-down workflows for applications such as biotherapeutic characterization, antibody analysis, covalent binder localization, native MS, and deep proteoform sequencing.</p><h5><strong>This webinar is designed for scientists working in:</strong></h5><ul><li>Intact protein analysis</li><li>Top-down proteomics</li><li>Native MS</li><li>Biotherapeutic characterization</li><li>Proteoform analysis</li><li>Protein complex or antibody characterization</li><li>Mass spectrometry core facilities supporting intact protein workflows</li></ul><p>If you are unable to attend the live webinar, please register to automatically receive a link to the on-demand recording.</p><blockquote><p><strong>Presenter: </strong>Jacob McCabe (Product Manager, Proteinaceous- Thermo Fisher Scientific)</p><p>Jacob McCabe, Ph.D., is a life-science innovator specializing in mass spectrometry, high-throughput automation, and software engineering who currently serves as a Product Manager at Thermo Fisher Scientific following the acquisition of Proteinaceous in March 2026. With a focus on translating complex research into scalable, user-centric digital solutions, he leads cross-functional teams to bridge laboratory instrumentation with automated workflows</p></blockquote></div></div></div>

Thermo Fisher Scientific: ASMS 2025 Workshops

Proteoform Studio software, top down made simple

Simplify top-down MS with Thermo Scientific Proteoform Studio. Learn how automated deconvolution and Direct Mass Technology™ analyze intact proteoforms

Proteoform Studio: Top-Down MS & Intact Protein Analysis

<p><strong>Achieving comprehensive antibody-drug conjugate (ADC) characterization no longer requires complex multi-step workflows. Advances in native LC-MS are creating new opportunities to simplify ADC analysis while maintaining the depth of information needed to support development decisions.</strong></p><p>In this SelectScience® TechTalk, Roxana Eggleston-Rangel, Senior Applications Scientist at Phenomenex, will showcase how Biozen® Native RP-1 and RP-5 columns enable direct drug-to-antibody ratio (DAR) analysis through a streamlined, MS-compatible native reverse-phase liquid chromatography-mass spectrometry (RP-LC-MS) workflow.</p><p>Learn how this approach supports DAR determination, proteoform characterization, and positional isomer resolution without fraction collection or buffer exchange while maintaining native conditions.</p><p>Using case studies featuring the approved ADC therapies Enhertu®, Padcev®, Polivy®, and Adcetris®, Eggleston-Rangel will demonstrate how this workflow can be applied across a range of ADC modalities and payload chemistries. In just 20 minutes, discover how the same approach can support both high-resolution mass spectrometry and routine UV-based DAR monitoring, bringing greater efficiency and confidence to ADC characterization.</p><h5><strong>Certificate of attendance</strong></h5><p>If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.</p><h5><strong>TechTalk details</strong></h5><ul><li>Cost: Free to attend</li><li>Location: Online</li><li>Duration: 20 minutes</li></ul><p>Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on-demand recording once it becomes available.</p><h5><strong>Who should attend?</strong></h5><p><strong>This event is perfect for:</strong></p><ul><li>Pharmaceutical and biopharmaceutical characterization scientists</li><li>Analytical development managers and directors overseeing LC-MS workflows</li><li>Researchers developing methods for ADC characterization, drug-to-antibody ratio (DAR) analysis, and isomer identification</li></ul><h5><strong>What will this webinar cover?</strong></h5><ul><li>How native RP chromatography can be used for streamlined ADC DAR characterization and intact mass analysis.</li><li>Best practices for selecting Biozen® Native RP columns based on ADC properties and analytical goals.</li><li>How a single workflow can provide DAR determination, proteoform characterization, and positional isomer information.</li><li>Real-world examples demonstrating how native RP-LC-MS can improve efficiency while reducing sample preparation complexity.</li></ul><h5><strong>Join the TechTalk to get answers to these questions:</strong></h5><ul><li>How can native RP-LC-MS simplify comprehensive ADC characterization workflows?</li><li>How do Biozen® Native RP-1 and RP-5 columns enable direct intact ADC analysis?</li><li>How is drug-to-antibody ratio (DAR) accurately determined under native conditions?</li><li>How can native RP-LC-MS resolve proteoforms and positional isomers in ADCs?</li><li>What insights were gained from case studies on Enhertu®, Padcev®, Polivy®, and Adcetris®?</li></ul><blockquote><p><strong>Speaker:</strong> Roxana Eggleston-Rangel (Senior Application Scientist, Phenomenex)</p><p>Roxana Eggleston-Rangel is a Senior Applications Scientist specializing in biopharmaceutical characterization workflows, with expertise in LC-MS, native chromatography, antibody-drug conjugates (ADCs), monoclonal antibodies, and protein biotherapeutics. She develops and evaluates analytical methods for critical quality attributes, including drug-to-antibody ratio (DAR), oxidation, isomerization, glycation, and fragmentation. Her work focuses on advancing innovative chromatographic and mass spectrometry solutions, generating application data, technical publications, and scientific content that help researchers improve characterization of complex biologics and next-generation therapeutics.</p></blockquote>

Phenomenex: TechTalk - ADC characterization in one native LC-MS workflow

ADC characterization in one native LC-MS workflow

Simplify ADC characterization with Phenomenex Biozen® Native RP columns. Learn direct DAR determination and proteoform profiling in one LC-MS workflow

Native LC-MS ADC Characterization: Phenomenex Biozen Columns

<div><div container-id="cq-colctrl-lt0" comp-id="A1"><div><p><strong>Join our experts for an in-depth look at the new Thermo Scientific™ Orbitrap™ Excedion™ Hybrid Mass Spectrometer—a next-generation HRAM platform designed to help laboratories confidently tackle today's analytical challenges while remaining ready for tomorrow's discoveries.</strong></p><p>Whether you're working in metabolomics, drug metabolism, environmental and food safety research, proteomics, or bioanalysis, the Orbitrap Excedion MS delivers the sensitivity, dynamic range, and robustness needed to detect more low-abundance compounds, improve confidence in your results, and maximize productivity. Learn how Full Scan Enhanced Dynamic Range (eDR) technology enables deeper sample coverage by revealing low-level analytes that conventional full-scan methods may miss, while maintaining outstanding quantitative performance.</p><p>This session will also explore how the Orbitrap Excedion platform is purpose-built for long-term value. With in-lab upgrade paths to the Orbitrap Excedion Pro MS, laboratories can expand capabilities as research needs evolve—protecting their investment without replacing their instrument. You'll also discover how a redesigned front-end, robust ion source, and simplified maintenance contribute to reliable, reproducible performance and greater uptime for busy laboratories.</p><p>Bring your questions and hear directly from our product experts about the innovations that are helping researchers generate more confident results today while preparing for the analytical challenges of tomorrow.</p><h4><strong>Who should attend?</strong></h4><ul><li>Scientists and laboratory managers seeking greater sensitivity, dynamic range, and confidence in HRAM mass spectrometry workflows.</li><li>Researchers working in metabolomics, DMPK, environmental and food safety, proteomics, bioanalysis, or other complex small-molecule applications.</li><li>Existing Orbitrap users and laboratories planning future instrument investments who want to understand the benefits of a scalable, upgradeable platform.</li></ul><h4><strong>What you can expect to learn</strong></h4><ul><li>How Full Scan Enhanced Dynamic Range (eDR) technology improves detection of low-abundance compounds and expands analytical coverage in complex samples.</li><li>How the Orbitrap Excedion MS delivers robust, reproducible performance with improved uptime, simplified operation, and reliable quantitative results.</li><li>How the platform's in-lab upgrade path enables your laboratory to add new capabilities as your research evolves, protecting your investment and future-proofing your workflows.</li></ul><blockquote><p><strong>Presenter: </strong>Maciej Bromirski (Sr. Product Marketing Manager, Thermo Fisher Scientific)</p><p>Maciej Bromirski has over 25 years of experience in mass spectrometry starting as an undergraduate student with late Prof. Ken Standing at the Physics Department at University of Manitoba in Winnipeg, Canada. Upon completion of his graduate studies on IR &amp; UV vacuum MALDI Q-TOF prototype MS with first oral presentation at ASMS and publications starting in 1999, Maciej undertook various roles and responsibilities with different Mass Spectrometry vendors. Since 2010 to present-day, Maciej has been fully dedicated to new product introductions and marketing developments of Q Exactive series, Orbitrap Exploris and more recently Orbitrap Excedion series MS with Thermo Fisher Scientific.</p><p><strong>Presenter: </strong>Claire Dauly (Senior Product Manager, Thermo Fisher Scientific)</p></blockquote></div></div></div>

Thermo Fisher Scientific: Ask the Expert: What to expect from the new Thermo Scientific™ Orbitrap™ Excedion™ Hybrid mass spectrometers

Ask the Expert: What to expect from the new Thermo Scientific™ Orbitrap™ Excedion™ Hybrid mass spectrometers

Explore the Orbitrap Excedion MS, featuring enhanced dynamic range, robust HRAM performance and an upgrade path to the Excedion Pro platform.

Related content

Why Biologics QC Is So Much Harder Than Small Molecule Pharma

Unassuming Start–Stop “Gates” Regulate Protein Production in Cells

The Helium Crisis Is Here: Why Laboratories Should Switch to Hydrogen Now